Outcomes of convergent atrial fibrillation ablation with continuous rhythm monitoring
- PMID: 32219901
- DOI: 10.1111/jce.14454
Outcomes of convergent atrial fibrillation ablation with continuous rhythm monitoring
Abstract
Background: Outcomes of catheter ablation for persistent atrial fibrillation (PeAF) are suboptimal. The convergent procedure (CP) may offer improved efficacy by combining endocardial and epicardial ablation.
Methods: We reviewed 113 consecutive patients undergoing the CP at our institution. The cohort was divided into two groups based on the presence (n = 92) or absence (n = 21) of continuous rhythm monitoring (CM) following the CP. Outcomes were reported in two ways. First, using a conventional definition of any atrial fibrillation/atrial tachycardia (AF/AT) recurrence lasting >30 seconds, after a 90 day blanking period. Second, by determining AF/AT burden at relevant time points in the group with CM.
Results: Across the entire cohort, 88% had either persistent or long-standing persistent AF, mean duration of AF diagnosis before the CP was 5.1 ± 4.6 years, 45% had undergone at least one prior AF ablation, 31% had impaired left ventricle ejection fraction and 62% met criteria for moderate or severe left atrial enlargement. Mean duration of follow-up after the CP was 501 ± 355 days. In the entire cohort, survival free from any AF/AT episode >30 seconds at 12 months after the blanking period was 53%. However, among those in the CM group who experienced recurrences, mean burden of AF/AT was generally very low (<5%) and remained stable over the duration of follow-up. Ten patients (9%) required elective cardioversion outside the 90 day blanking period, 11 patients (9.7%) underwent repeat ablation at a mean of 229 ± 178 days post-CP and 64% were off AADs at the last follow-up. Procedural complications decreased significantly following the transition from transdiaphragmatic to sub-xiphoid surgical access: 23% versus 3.8% (P = .005) CONCLUSIONS: In a large, consecutive series of patients with predominantly PeAF, the CP was capable of reducing AF burden to very low levels (generally <5%), which appeared durable over time. Complication rates associated with the CP decreased significantly with the transition from transdiaphragmatic to sub-xiphoid surgical access. Future trials will be necessary to determine which patients are most likely to benefit from the convergent approach.
Keywords: ablation; atrial fibrillation; convergent ablation; surgical atrial fibrillation ablation.
© 2020 Wiley Periodicals, Inc.
Comment in
-
Convergent atrial fibrillation ablation-Focus on the epicardium.J Cardiovasc Electrophysiol. 2020 Jun;31(6):1277-1278. doi: 10.1111/jce.14453. Epub 2020 Mar 30. J Cardiovasc Electrophysiol. 2020. PMID: 32202011 No abstract available.
References
REFERENCES
-
- Clarnette JA, Brooks AG, Mahajan R, et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis. Europace. 2018;20:f366-f376.
-
- Verma A, Macle L. Persistent atrial fibrillation ablation: where do we go from here? Can J Cardiol. 2018;34:1471-1481.
-
- Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275-e444.
-
- Cheniti G, Vlachos K, Pambrun T, et al. Atrial fibrillation mechanisms and implications for catheter ablation. Front Physiol. 2018;9:1458.
-
- Della Rocca DG, Mohanty S, Trivedi C, Di Biase L, Natale A. Percutaneous treatment of non-paroxysmal atrial fibrillation: a paradigm shift from pulmonary vein to non-pulmonary vein trigger ablation? Arrhythm Electrophysiol Rev. 2018;7:256-260.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical